Home › Adenocarcinoma esofageo › Virginia › Arlington
Studi clinici su Adenocarcinoma esofageo a Arlington, VA
11 studi su Adenocarcinoma esofageo cercano partecipanti presso sedi a Arlington e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
In reclutamentoFase 3
- Inova Fairfax Hospital, Falls Church · a 4 mi di distanza
- Inova Schar Cancer Institute, Fairfax · a 11 mi di distanza
- Inova Fair Oaks Hospital, Fairfax · a 11 mi di distanza
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
In reclutamentoFase 1/2
- Inova Schar Cancer Institute, Fairfax · a 11 mi di distanza
- Virginia Cancer Specialists, PC, Fairfax · a 11 mi di distanza
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
In reclutamentoFase 2/3
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · a 11 mi di distanza
- Virginia Cancer Specialists, PC, Reston · a 14 mi di distanza
- e altri 1
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Oncology Virginia, Fairfax · a 11 mi di distanza
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
In reclutamentoFase 3
- Research Site, Fairfax · a 11 mi di distanza
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
In reclutamentoFase 1
- Normunity Investigational Site, Fairfax · a 11 mi di distanza
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
In reclutamentoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
In reclutamentoFase 1
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1
- Research Site, Fairfax · a 11 mi di distanza
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Virginia, Fairfax · a 11 mi di distanza
Studi su Adenocarcinoma esofageo in altre città
- New York City, NY18 studi
- Boston, MA13 studi
- Houston, TX12 studi
- Nashville, TN11 studi
- Durham, NC10 studi
- Rochester, MN9 studi
- Baldwin Park, CA9 studi
- St. Louis, MO9 studi
- Jacksonville, FL9 studi
- Queens, NY9 studi
- Los Angeles, CA9 studi
- Philadelphia, PA8 studi
Altri studi a Arlington
- Cancro del polmone non a piccole cellule104 studi
- Cancro metastatico53 studi
- Cancro colorettale52 studi
- Cancro (tutti i tipi)48 studi
- Cancro al seno47 studi
- Cancro ovarico46 studi
- Cancro ai polmoni41 studi
- Cancro dell'endometrio39 studi
- Cancro pancreatico33 studi
- Carcinoma a cellule squamose della testa e del collo26 studi
- Carcinoma polmonare a piccole cellule23 studi
- Cancro dello stomaco20 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.